-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Serendipity and Lessons Learned about Clonal Hematopoiesis in the Cantos Study

Scientific Workshop on Clonal Hematopoiesis
Program: Scientific Workshops
Session: Clinical Trial Approaches in Clonal Hematopoiesis
Friday, December 6, 2024, 3:50 PM-4:55 PM

David P. Steensma, MD

Ajax Therapeutics, Cambridge, MA

Disclosures: Steensma: Ajax Therapeutics: Current Employment; Novartis Pharmaceuticals: Ended employment in the past 24 months; Bluebird Bio: Divested equity in a private or publicly-traded company in the past 24 months; Arrowhead: Divested equity in a private or publicly-traded company in the past 24 months; Gamida Cell: Divested equity in a private or publicly-traded company in the past 24 months.

See more of: Clinical Trial Approaches in Clonal Hematopoiesis
See more of: Scientific Workshop on Clonal Hematopoiesis
See more of: Scientific Workshops
<< Previous Presentation | Next Presentation